These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37405409)

  • 1. The potential for rapid antigen testing for mucormycosis in the context of COVID-19.
    Thornton CR
    Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.
    Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M
    Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM).
    Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S
    Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis.
    Chen X; Xiao J; Wang X; Lu X; An J; Zhao J; Wei J; Wei J; He S; Tian W
    Ann Hematol; 2023 Oct; 102(10):2933-2942. PubMed ID: 37421505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
    Lynch JP; Fishbein MC; Abtin F; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):723-736. PubMed ID: 37262298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucormycosis: update on clinical presentation, diagnosis, and treatment.
    Dailey Garnes NJM; Kontoyiannis DP
    Curr Opin Infect Dis; 2023 Dec; 36(6):427-435. PubMed ID: 37732771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
    Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
    Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucormycosis and stroke: The learning curve during the second COVID-19 pandemic.
    Ramachandran D; R A; Panicker P; S J; Sathyabhama MC; Nair A; Chandran RS; George S; S C; Iype T
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106819. PubMed ID: 36495645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.